Adial Pharmaceuticals, Inc. Increase (Decrease) in Other Operating Liabilities
Adial Pharmaceuticals, Inc. (ADIL) reported Increase (Decrease) in Other Operating Liabilities of -$11.81 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2022-05-16
- Adial Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for the quarter ending 2022-03-31 was -$11.81K.
- Adial Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for the quarter ending 2021-12-31 was -$11.11K.
- Adial Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for the quarter ending 2021-09-30 was -$5.22K.
- Adial Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for the quarter ending 2021-06-30 was -$10.62K.
- Adial Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for fiscal 2021 was -$37.34K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$11.81K 10-Q · filed 2022-05-16 | -$22.92K derived: sum of 2 quarters · filed 2022-05-16 | -$28.14K derived: sum of 3 quarters · filed 2022-05-16 | -$38.76K derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | -$11.11K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$16.33K derived: sum of 2 quarters · filed 2022-03-28 | -$26.95K derived: sum of 3 quarters · filed 2022-03-28 | -$37.34K 10-K · filed 2022-03-28 |
| 2021-09-30 | -$5.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$15.84K derived: sum of 2 quarters · filed 2021-11-15 | -$26.23K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$10.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$21.01K 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | -$10.39K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |